In the Journals

CTR-blocked angle increases IOP in chronic hypotony

April 25, 2019
Patients who underwent a novel surgical method to treat chronic ocular hypotony experienced increased IOP and visual acuity through a mean 27.7-month…

Aerie aims multi-kinase inhibitor at retinal disease

April 25, 2019
The FDA has accepted Aerie Pharmaceuticals’ investigational new drug application for the AR-13503 implant, the company’s treatment…

Allegro introduces dry eye treatment candidate

April 25, 2019
Allegro Ophthalmics has added ALG-1007, a new anti-integrin drug candidate for the treatment of dry eye disease, to its portfolio, the company…
Blog

BLOG: Dissecting DREAM Part 4: Why all the fuss?

April 25, 2019
Boy, has there been a lot of noise about the DREAM study, or what?! I mean, come ON! We’re talking about fish oil here. Not some life-saving…
In the Journals

VA improves in astigmatic eyes after 2-step procedure

April 24, 2019
Both visual acuity and refractive results improved in patients undergoing deep intrastromal arcuate keratotomy with in situ keratomileusis for…

Oxurion completes enrollment in plasma kallikrein inhibitor trial

April 24, 2019
Oxurion NV has completed enrollment in a phase 1 study of its plasma kallikrein inhibitor for treatment of diabetic macular edema, according to a…

Xbrane sets sales goals for ranibizumab biosimilar

April 24, 2019
Xbrane Biopharma has begun a phase 3 trial of its lead product Xlucane and announced a sales target for the biosimilar, according to a press release…

2CTech begins nanoparticle retina treatment trials

April 24, 2019
2CTech Inc. has initiated a clinical trial program for quantum dots, a nanoparticle technology treatment candidate for retinal diseases, according to…
Video

VIDEO: Small relaxing incisions may allow easier DMEK surgery

April 23, 2019
Mark S. Hansen, MD, and David R. Hardten, MD, demonstrate a novel technique that facilitates performance of Descemet’s membrane endothelial…

Specialists offer their perspectives at Cornea360

April 23, 2019
The inaugural Cornea360 meeting took place in Scottsdale, Arizona, earlier this month, bringing together cornea specialists from across the country. …

Research shows microglia may control neuroinflammation

April 23, 2019
Research from Massachusetts Eye and Ear has shown that microglia may serve as facilitators of neuroinflammation in autoimmune uveitis. Researchers…

FDA approves generic tobramycin from Alembic

April 23, 2019
The FDA has approved an abbreviated new drug application for Alembic Pharmaceuticals’ tobramycin ophthalmic solution USP 0.3%, according to a…

Ophthalmologists push for better access to care in annual Capitol Hill visit

April 22, 2019
In an effort to lobby for better access to care, discuss important issues with lawmakers and increase education, more than 400 ophthalmologists…

Rocklatan approval tops recent glaucoma news

April 22, 2019
The FDA’s approval of Rocklatan and news updates from the American Glaucoma Society meeting were among the most-read glaucoma-related articles…

Bausch + Lomb to initiate clinical trials for Technolas Teneo excimer laser

April 22, 2019
Bausch + Lomb will begin a clinical trial series of its Technolas Teneo excimer laser for vision correction surgery, the company announced in a press…

FDA approves generic loteprednol etabonate from Akorn

April 22, 2019
The FDA has approved an abbreviated new drug application for Akorn’s loteprednol etabonate ophthalmic suspension 0.5%, according to a press…

Depo-Medrol warning tops OSN’s news of the week

April 21, 2019
Here are some of the top stories on Healio.com/OSN in the past week:

OSN’s Publication Exclusives focus on preparing for future of ophthalmology

April 20, 2019
The April 25 issue of Ocular Surgery News focuses on practice management and prepping for how ophthalmic care will work in the future. Read some of…
Meeting NewsVideo

VIDEO: Keynote lecture on megatrends in ophthalmology

April 18, 2019
ORLANDO — At Cataract Surgery: Telling It Like It Is, Richard L. Lindstrom, MD, delivers his keynote lecture on megatrends in ophthalmology…

First patient dosed in Innovent wet AMD trial

April 18, 2019
Innovent Biologics has dosed the first patient in a phase 1 trial of IBI302, the company’s wet age-related macular degeneration treatment…